Literature DB >> 18673279

The antipathogen activities of eosinophil cationic protein.

Ester Boix1, Marc Torrent, Daniel Sánchez, Maria Victòria Nogués.   

Abstract

The eosinophil cationic protein (ECP) is a secretory ribonuclease, which is found in the eosinophilic leukocyte and involved in the innate immune system. Its cytotoxic activity is effective against a wide range of pathogens, suggesting a relatively non-specific mechanism of action. We review here the specific antipathogen activities that have been characterized for ECP. Although eosinophils and ECP are primarily associated with the host defense against nonphagocytosable pathogens, such as helminthic parasites, ECP has also an antibacterial activity, which is not shared by the other, closely-related eosinophil ribonuclease, the eosinophil derived neurotoxin (EDN). Although there is no evidence for direct involvement in vivo of eosinophils in the host response to bacterial infection, ECP is active against both Gram-negative and Gram-positive bacterial strains and its mechanism depends on its action both at the bacterial cell wall and cytoplasmic membrane levels. Other antipathogen activities, including antihelminthic activity, are also discussed. Modulation of the protein activity by posttranslational modifications and the currently identified polymorphisms are reviewed. Antimicrobial RNases, as innate immune proteins with anti-infective and immunomodulatory properties, present substantial therapeutic potential in the drug development industry, both in the search of alternative antibiotics and for the treatment of inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673279     DOI: 10.2174/138920108784567353

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  19 in total

1.  Proteolytic activation transforms heparin cofactor II into a host defense molecule.

Authors:  Martina Kalle; Praveen Papareddy; Gopinath Kasetty; Douglas M Tollefsen; Martin Malmsten; Matthias Mörgelin; Artur Schmidtchen
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

2.  Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.

Authors:  David Pulido; Mohammed Moussaoui; David Andreu; M Victòria Nogués; Marc Torrent; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

3.  NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics.

Authors:  María Flor García-Mayoral; Mohammed Moussaoui; Beatriz G de la Torre; David Andreu; Ester Boix; M Victòria Nogués; Manuel Rico; Douglas V Laurents; Marta Bruix
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

4.  Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.

Authors:  David Pulido; Marc Torrent; David Andreu; M Victoria Nogués; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

Review 5.  Eosinophils in glioblastoma biology.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Neuroinflammation       Date:  2012-01-17       Impact factor: 8.322

Review 6.  A Review of Ribonuclease 7's Structure, Regulation, and Contributions to Host Defense.

Authors:  Brian Becknell; John David Spencer
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923

7.  Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation.

Authors:  David Pulido; Javier Arranz-Trullén; Guillem Prats-Ejarque; Diego Velázquez; Marc Torrent; Mohammed Moussaoui; Ester Boix
Journal:  Int J Mol Sci       Date:  2016-04-13       Impact factor: 5.923

8.  A theoretical approach to spot active regions in antimicrobial proteins.

Authors:  Marc Torrent; Victòria M Nogués; Ester Boix
Journal:  BMC Bioinformatics       Date:  2009-11-11       Impact factor: 3.169

9.  Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation.

Authors:  Marc Torrent; David Pulido; M Victòria Nogués; Ester Boix
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

10.  Human antimicrobial peptides and proteins.

Authors:  Guangshun Wang
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.